What Interscope does

Interscope, Inc. (operating as Interscope Medical) is a privately held medical device company headquartered in Northbridge, Massachusetts, with manufacturing operations in Whitinsville, MA and customer support offices in Amsterdam and the United Kingdom. Founded in 2011 by Jeffery Ryan, Jr. (President & CEO) and Ramon A. Franco, Jr., MD (Chief Scientific Officer), the company develops and commercializes the EndoRotor system, a powered endoscopic platform for interventional gastroenterology and pulmonology procedures. The EndoRotor is a 3-in-1 interventional tool that simultaneously dissects, resects, and collects tissue via a rotating blade integrated into a disposable catheter with suction and continuous irrigation, controlled by foot pedals from a separate electronic console. Two primary clinical applications are commercially available: Endoscopic Powered Resection (EPR), FDA 510(k) cleared for removing scarred and residual GI tissue following EMR, and Powered Endoscopic Debridement (PED), FDA De Novo authorized for necrotic tissue removal in symptomatic walled-off pancreatic necrosis after EUS-guided drainage. Supporting products include the EndoRotor Catheter Guide accessory and an electronic Instructions for Use (eIFU) digital platform.

The company sells its system primarily through direct sales to gastroenterologists, interventional endoscopists, and advanced endoscopy centers, with reference adoption at leading U.S. academic medical centers including Mayo Clinic, Duke University Medical Center, Montefiore Medical Center, the University of Alabama at Birmingham, the University of Minnesota, and the University of Illinois College of Medicine, plus Erasmus Medical Center Rotterdam internationally. Revenue is generated via hardware sales of the capital console plus recurring disposable catheter revenue per procedure. The company pursues a clinical-evidence-led go-to-market strategy, leveraging peer-reviewed publications, an Investigator-Initiated Study Program, the EndoRotor University physician training platform, and presence at major gastroenterology conferences (DDW, UEG Week, ESGE). The company is ISO 13485 certified and holds registered U.S. trademarks for the EndoRotor and Interscope brands.

Name

Interscope

Legal name

Interscope, Inc.

Website

https://interscopemed.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Interscope Medical is a privately held medical device company that develops and sells the EndoRotor, an FDA-cleared powered endoscopic system for advanced GI procedures including pancreatic necrosectomy and post-EMR tissue resection. It sells directly to gastroenterologists and academic medical centers performing interventional endoscopy.

Ownership category

akta.pro rank

Product category

Interventional Endoscopy Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Endoscopic tissue resection
• Interventional endoscopy devices
• Medical device manufacturing
• Powered endoscopic debridement
• Gastrointestinal therapeutic devices

Headquarters

HQ city

Whitinsville

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. EndoRotor System Sales: Interscope generates revenue through the sale of its EndoRotor medical device system, including the console and disposable catheters. The system is sold to gastroenterologists and hospitals for use in endoscopic procedures including necrosectomy and powered endoscopic resection.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Interscope designs, manufactures and sells the EndoRotor® system, a powered endoscopic mechanical tissue resection platform used by trained gastroenterologists. The system consists of a reusable electronic console and disposable single-use catheters (EPR for Endoscopic Powered Resection and PED for Powered Endoscopic Debridement) that aspirate, cut and collect GI tissue at 1000 or 1700 RPM, addressing endoscopic necrosectomy of pancreatic walled-off necrosis and resection of scarred, non-lifting or residual post-EMR lesions.

Product overview

Interscope is a medical device company that has developed the EndoRotor® system, a portfolio of interventional endoscopic devices. The core offering is the EndoRotor® console (capital equipment) combined with single-use catheter modules. Two main clinical applications exist: Endoscopic Powered Resection (EPR) for removing scarred and residual GI tissue, and Powered Endoscopic Debridement (PED) for pancreatic necrosectomy. Accessories include the Catheter Guide (auxiliary working channel). Supporting the hardware is an eIFU digital platform for electronic instructions for use.

Differentiator

Problem solved

Functional benefit

Products and services

• EndoRotor® System 3-in-1 interventional endoscopic tool that simultaneously dissects, resects and collects tissue by aspirating tissue into the catheter tip where it is cut by a rotating blade and transported into a tissue trap; designed for trained gastroenterologists performing endoscopic necrosectomy, incomplete resection and post-EMR scarred lesions.
• EndoRotor® EPR Catheter (Endoscopic Powered Resection) FDA 510(k) cleared single-use catheter module for resecting and removing tissue of the gastrointestinal system, including post-EMR tissue persistence with scarred base and residual tissue from peripheral margins following EMR; intended for use by trained gastroenterologists.
• EndoRotor® PED Catheter (Powered Endoscopic Debridement) FDA De Novo cleared single-use catheter indicated to resect and remove necrotic tissue in symptomatic walled-off pancreatic necrosis (WOPN/WON) after EUS-guided drainage; positioned as the first clinically validated solution for endoscopic debridement of WON.
• EndoRotor® Catheter Guide Accessory device providing a 6mm auxiliary working channel for the EndoRotor Catheter during procedures, compatible with most diagnostic gastroscopes with combined outer diameter of 19.3mm-17.2mm when attached.
• EndoRotor® Console Reusable electronic console that powers and controls the EndoRotor catheter, driving the motorized rotating cutting tool at 1000 or 1700 RPM via two foot pedals that activate blade rotation and suction respectively.
• EndoRotor® eIFU (Electronic Instructions for Use) Digital platform that delivers electronic instructions for use for Interscope products, searchable by product name, GTIN or product code.

Named customers8 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cook Medical: Cook Medical is a privately held broad-line medical device manufacturer with a sizable GI endoscopy portfolio, including stents and drainage devices used in walled-off necrosis management. It serves the same advanced endoscopy and academic center customer base, making it a comparable incumbent in the adjacent necrosectomy workflow.
• Fujifilm Healthcare: Fujifilm's Healthcare division supplies GI endoscopy systems, scopes, and accessories to gastroenterology departments worldwide. It is a broad incumbent selling overlapping capital equipment and consumables into the same advanced endoscopy centers.
• STERIS: STERIS is a broad medical device and infection prevention company with endoscopy-adjacent reprocessing products (AERs, endoscope storage) and GI surgical instruments. Its endoscopy reprocessing leadership gives it incumbent relationships with the same hospital endoscopy departments that adopt EndoRotor.
• Pentax Medical (HOYA Corporation): Pentax Medical is a major GI endoscopy equipment and accessory manufacturer, competing head-to-head with Olympus and Fujifilm in flexible endoscopes. It sells into the same gastroenterology customer base as Interscope, though without a direct powered mechanical resection equivalent to EndoRotor.
• Boston Scientific: Boston Scientific's Endoscopy division sells a broad portfolio of GI therapeutic devices, including hemostasis, dilation, and resection products, into the same gastroenterology accounts as Interscope. It is a broad incumbent in powered and mechanical GI intervention rather than a direct like-for-like powered resection competitor.
• CONMED Corporation: CONMED sells GI endoscopy and general surgery devices, including electrosurgical and mechanical tissue resection tools used by gastroenterologists. It serves overlapping procedural customers with broader product breadth but lacks a powered mechanical resection system directly comparable to EndoRotor.
• Olympus Corporation: Olympus is the dominant global GI endoscopy platform with a broad portfolio of scopes, electrosurgical tools, and accessories used by gastroenterologists. It sells overlapping capital and consumable endoscopy solutions to the same hospital customer base Interscope targets, but does not currently offer a powered mechanical resection device equivalent to EndoRotor.
• Medtronic: Medtronic is a diversified medtech incumbent with GI Solutions (formerly Given Imaging) for capsule endoscopy and broader surgical technologies. It targets overlapping gastroenterology and advanced endoscopy accounts and has the scale to enter the powered endoscopic resection category if commercially attractive.

Emerging players

• Apollo Endosurgery: Apollo Endosurgery develops endoscopic suturing and tissue management devices used by gastroenterologists for bariatric and complex GI procedures. As an emerging endoscopic interventional player, it serves an overlapping interventional endoscopist customer base and competes for the same specialty GI accounts.
• USGI Medical: USGI Medical is an emerging endoscopic device company developing tissue approximation and revision tools for GI endoscopy. As a smaller, indication-focused player, it overlaps with Interscope's gastroenterologist customer base and shares the niche, advanced-endoscopy commercial model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/InterscopeMed
• LinkedInlinkedin.com/company/interscopemedical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Interscope